The Singapore-based company is starting investor-education meetings on Tuesday, according to terms of the deal seen by Bloomberg News. The offering is targeting to raise about $400 million in a listing as early as December, according to people familiar with the matter, who asked not to be identified discussing private information.
Proceeds will be used for developing core products and other fluorescence-guided surgery technologies, as well as strategic investments, acquisitions, global expansion and general corporate purposes, deal ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
